Literature DB >> 14744982

Superior 5' homogeneity of RNA from ATP-initiated transcription under the T7 phi 2.5 promoter.

Tricia M Coleman1, Guocan Wang, Faqing Huang.   

Abstract

Transcription from the commonly used GTP- initiating T7 class III promoter phi6.5 frequently produces heterogeneous RNA at both 3' and 5' ends. We demonstrate here that RNA transcripts from the T7 class II promoter phi2.5 have superior 5' homogeneity over those from the phi6.5 promoter, with comparable total RNA yields. The overall homogeneity of RNA transcripts is improved to different degrees depending on RNA sequences, although transcription under phi2.5 does not affect the 3' heterogeneity of RNA. In combination with 3' RNA trimming by DNAzymes or ribozymes, this ATP- initiated transcription system based on the T7 phi2.5 promoter can provide excellent quality of RNA for applications requiring a high degree of RNA size homogeneity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744982      PMCID: PMC373309          DOI: 10.1093/nar/gnh007

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  26 in total

1.  A simple and efficient method to reduce nontemplated nucleotide addition at the 3 terminus of RNAs transcribed by T7 RNA polymerase.

Authors:  C Kao; M Zheng; S Rüdisser
Journal:  RNA       Date:  1999-09       Impact factor: 4.942

2.  NMR solution structure determination of RNAs.

Authors:  E T Mollova; A Pardi
Journal:  Curr Opin Struct Biol       Date:  2000-06       Impact factor: 6.809

3.  A simple and efficient method to transcribe RNAs with reduced 3' heterogeneity.

Authors:  C Kao; S Rüdisser; M Zheng
Journal:  Methods       Date:  2001-03       Impact factor: 3.608

Review 4.  NMR spectroscopy of RNA.

Authors:  Boris Fürtig; Christian Richter; Jens Wöhnert; Harald Schwalbe
Journal:  Chembiochem       Date:  2003-10-06       Impact factor: 3.164

5.  A universal method to produce in vitro transcripts with homogeneous 3' ends.

Authors:  Heike Schürer; Kathrin Lang; Jens Schuster; Mario Mörl
Journal:  Nucleic Acids Res       Date:  2002-06-15       Impact factor: 16.971

6.  RNA-catalyzed thioester synthesis.

Authors:  Tricia M Coleman; Faqing Huang
Journal:  Chem Biol       Date:  2002-11

7.  General plasmids for producing RNA in vitro transcripts with homogeneous ends.

Authors:  Scott C Walker; Johanna M Avis; Graeme L Conn
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

8.  Complete nucleotide sequence of bacteriophage T7 DNA and the locations of T7 genetic elements.

Authors:  J J Dunn; F W Studier
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

9.  Efficient incorporation of CoA, NAD and FAD into RNA by in vitro transcription.

Authors:  Faqing Huang
Journal:  Nucleic Acids Res       Date:  2003-02-01       Impact factor: 16.971

10.  Synthesis of adenosine derivatives as transcription initiators and preparation of 5' fluorescein- and biotin-labeled RNA through one-step in vitro transcription.

Authors:  Faqing Huang; Guocan Wang; Tricia Coleman; Na Li
Journal:  RNA       Date:  2003-12       Impact factor: 4.942

View more
  56 in total

1.  Synthesis of 5' cap-0 and cap-1 RNAs using solid-phase chemistry coupled with enzymatic methylation by human (guanine-N⁷)-methyl transferase.

Authors:  Yann Thillier; Etienne Decroly; François Morvan; Bruno Canard; Jean-Jacques Vasseur; Françoise Debart
Journal:  RNA       Date:  2012-02-14       Impact factor: 4.942

2.  mRNAs biotinylated within the 5' cap and protected against decapping: new tools to capture RNA-protein complexes.

Authors:  Sylwia Bednarek; Vanesa Madan; Pawel J Sikorski; Ralf Bartenschlager; Joanna Kowalska; Jacek Jemielity
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-11-05       Impact factor: 6.237

3.  The 2'-O-ribose methyltransferase for cap 1 of spliced leader RNA and U1 small nuclear RNA in Trypanosoma brucei.

Authors:  Jesse R Zamudio; Bidyottam Mittra; Silvie Foldynová-Trantírková; Gusti M Zeiner; Julius Lukes; Janusz M Bujnicki; Nancy R Sturm; David A Campbell
Journal:  Mol Cell Biol       Date:  2007-07-02       Impact factor: 4.272

4.  Initiation of RNA decay in Escherichia coli by 5' pyrophosphate removal.

Authors:  Helena Celesnik; Atilio Deana; Joel G Belasco
Journal:  Mol Cell       Date:  2007-07-06       Impact factor: 17.970

5.  Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex.

Authors:  Yuanyuan Ma; Lijie Wu; Neil Shaw; Yan Gao; Jin Wang; Yuna Sun; Zhiyong Lou; Liming Yan; Rongguang Zhang; Zihe Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-09       Impact factor: 11.205

6.  mRNA cap analogues substituted in the tetraphosphate chain with CX2: identification of O-to-CCl2 as the first bridging modification that confers resistance to decapping without impairing translation.

Authors:  Anna M Rydzik; Marcin Warminski; Pawel J Sikorski; Marek R Baranowski; Sylwia Walczak; Joanna Kowalska; Joanna Zuberek; Maciej Lukaszewicz; Elzbieta Nowak; Timothy D W Claridge; Edward Darzynkiewicz; Marcin Nowotny; Jacek Jemielity
Journal:  Nucleic Acids Res       Date:  2017-09-06       Impact factor: 16.971

Review 7.  RNA synthesis and purification for structural studies.

Authors:  Yasar Luqman Ahmed; Ralf Ficner
Journal:  RNA Biol       Date:  2014-02-10       Impact factor: 4.652

8.  Mouse embryonic stem cells have underdeveloped antiviral mechanisms that can be exploited for the development of mRNA-mediated gene expression strategy.

Authors:  Ruoxing Wang; Chengwen Teng; Joseph Spangler; Jundi Wang; Faqing Huang; Yan-Lin Guo
Journal:  Stem Cells Dev       Date:  2013-12-20       Impact factor: 3.272

9.  Specificity of RppH-dependent RNA degradation in Bacillus subtilis.

Authors:  Ping-kun Hsieh; Jamie Richards; Quansheng Liu; Joel G Belasco
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

10.  In vitro reconstitution of SARS-coronavirus mRNA cap methylation.

Authors:  Mickaël Bouvet; Claire Debarnot; Isabelle Imbert; Barbara Selisko; Eric J Snijder; Bruno Canard; Etienne Decroly
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.